Suppliers / JW Pharmaceutical

JW Pharmaceutical

South Korea 2 duplicate records merged Updated 9 July 2026

JW Pharmaceutical is an API manufacturer based in South Korea. It holds one active US drug master file. Its filings concentrate with DAV (Vietnam) and MINSA (CR).

1
active US DMFs
0
valid CEPs
1
registered plants
10
filings across 2 regulators

Registered plants

Site FDA FEI
DANGJIN, South Korea Not on file

What they file, and where

Molecule Regulators Docs
Cilastatin US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 8 None
MINSA (CR) 2 None

Questions about JW Pharmaceutical

Does JW Pharmaceutical hold a US DMF or a CEP?
JW Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does JW Pharmaceutical manufacture?
1 registered site is on record, in South Korea (Dangjin). Every site is listed on this page with the register it came from.
What does JW Pharmaceutical make?
1 molecule is on record against JW Pharmaceutical, including Cilastatin. Each links through to that molecule's full manufacturer list.
Where does JW Pharmaceutical file?
Filings are on record with DAV (Vietnam) and MINSA (CR), 10 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. JW Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability